C. BUSCH Et Al. , "Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.," Acta diabetologica , vol.55, pp.789-796, 2018
BUSCH, C. Et Al. 2018. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.. Acta diabetologica , vol.55 , 789-796.
BUSCH, C., ZUR, D., FRASER-BELL, S., LAÍNS, I., SANTOS, A., LUPIDI, M., ... CAGINI, C.(2018). Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.. Acta diabetologica , vol.55, 789-796.
BUSCH, C Et Al. "Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.," Acta diabetologica , vol.55, 789-796, 2018
BUSCH, C Et Al. "Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.." Acta diabetologica , vol.55, pp.789-796, 2018
BUSCH, C. Et Al. (2018) . "Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.." Acta diabetologica , vol.55, pp.789-796.
@article{article, author={C BUSCH Et Al. }, title={Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.}, journal={Acta diabetologica}, year=2018, pages={789-796} }